相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
Noriaki Sunaga et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells
Zhenfeng Zhang et al.
CARCINOGENESIS (2010)
CLINICOPATHOLOGICAL AND THERAPEUTIC SIGNIFICANCE OF CXCL12 EXPRESSION IN LUNG CANCER
H. Imai et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations
Satoshi Morita et al.
CLINICAL CANCER RESEARCH (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Yeriel Estrada et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier
Masahiro Seike et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Erminia Massarelli et al.
CLINICAL CANCER RESEARCH (2007)
Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1α-directed invasion of human basal cell carcinoma cells
C-Y Chu et al.
ONCOGENE (2007)
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation
F. Luppi et al.
LUNG CANCER (2007)
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Avrum Spira et al.
NATURE MEDICINE (2007)
Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology
Yasumasa Mitani et al.
NATURE METHODS (2007)
A translational view of the molecular pathogenesis of lung cancer
Mitsuo Sato et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients:: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features
Fiamma Buttitta et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
High expression of Ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras
M Wislez et al.
CANCER RESEARCH (2006)
Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells
M Sato et al.
CANCER RESEARCH (2006)
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells
PL Yao et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Current management of advanced non-small cell lung cancer: Targeted therapy
T Isobe et al.
SEMINARS IN ONCOLOGY (2005)
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
C Mascaux et al.
BRITISH JOURNAL OF CANCER (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
YM Zhu et al.
BRITISH JOURNAL OF CANCER (2004)
Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer
N Sunaga et al.
CANCER RESEARCH (2004)
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
A Sparmann et al.
CANCER CELL (2004)
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells
M Suzuki et al.
CANCER RESEARCH (2004)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Regulation of human airway epithelial cell IL-8 expression by MAP kinases
J Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Smoking and airway inflammation in patients with mild asthma
GW Chalmers et al.
CHEST (2001)
Suppression of IL-8 gene expression by radicicol is mediated through the inhibition of ERK1/2 and p38 signaling and negative regulation of NF-κB and AP-1
YJ Na et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
A Yuan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
